Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy.

Abdulrahman JamaAbdullah A AlshudukhiSteve BurkeLixin DongJohn Karanja KamauBrooklyn MorrisIbrahim A AlkhomsiBrian N FinckAndrew Alvin VossHongmei Ren

Published in: Journal of translational medicine (2024)

Overall, our data suggest that lipin1 is a promising therapeutic target for the treatment of dystrophic muscles.

Keyphrases

duchenne muscular dystrophy
combination therapy
electronic health record
artificial intelligence